GMED
Globus Medical
75.60$
+1.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5.0% | -2.8% | +1.0% | +1.8% | +3.3% | -10.3% | +5.3% | +2.7% | +4.1% | +2.6% | +0.9% | |
| – | -0.1% | -4.5% | +5.2% | +6.9% | +5.9% | -21.5% | +1.2% | +11.2% | +10.5% | +3.4% | +0.8% | |
| – | +67.1% | -24.2% | +15.9% | +51.7% | +26.0% | -41.2% | -50.3% | +62.0% | +41.5% | +6.6% | -9.5% | |
| – | +10.4% | -16.1% | +13.5% | +40.9% | +28.1% | -48.2% | -50.3% | +70.2% | +42.7% | +13.0% | -5.5% | |
| – | +1.8% | +5.9% | +14.9% | -3.4% | -2.5% | -7.0% | +22.7% | +4.2% | +8.1% | -1.1% | +0.5% | |
| – | -6.3% | -3.8% | -5.6% | -6.8% | -8.1% | +0.7% | +16.4% | -0.1% | -1.6% | +1.8% | +5.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +27.8% | +1.2% | +0.2% | -1.5% | +0.1% | +0.0% | +0.1% | 0.0% | +0.1% | +0.3% | 0.0% | |
| – | -26.7% | -3.9% | -2.4% | -2.7% | -5.7% | -2.9% | +3.2% | -2.8% | -3.7% | -3.3% | -3.9% | |
| – | -6.9% | -6.1% | -0.4% | -0.1% | +5.7% | -42.0% | +6.8% | +4.7% | +4.7% | -3.1% | +1.8% | |
| – | -8.5% | +100.4% | +1.0% | +3.0% | +4.6% | -55.1% | +10.4% | +9.7% | +7.0% | -3.2% | -0.6% | |
| – | -10.6% | +3,541.6% | +1.3% | +1.5% | +1.2% | -97.7% | +24.1% | +8.9% | +2.7% | +2.6% | -4.9% | |
| – | -34.8% | -10.9% | +33.0% | -14.3% | +30.6% | -2.6% | +19.1% | +0.1% | +13.3% | +4.9% | +3.2% | |
| – | +1.9% | – | – | – | – | – | – | – | – | – | – | |
| – | -4.5% | -1.9% | +1.4% | +2.3% | +2.7% | -2.1% | +5.1% | +2.4% | +4.0% | +3.5% | +0.8% | |
| – | -15.6% | -8.0% | +2.6% | +4.8% | +2.4% | -10.1% | +17.1% | +6.5% | +7.4% | +9.0% | +1.0% | |
| – | +20.6% | -2.6% | +1.2% | +0.8% | +1.2% | +0.0% | -2.3% | -0.8% | +1.3% | +0.7% | +0.0% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.